Wei Cang
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
-
- Immune cells in cancer
Papers in
-
- Epigenetics and DNA Methylation 2
-
- Ferroptosis and cancer prognosis 1
- Co-authors
- Yu Gu (8 shared papers)Lihua Chen (6 shared papers)Pengming Sun (3 shared papers)Yang Xiang (1 shared paper)Lihua Qiu (6 shared papers)Liying Gu (5 shared papers)Anyue Wu (4 shared papers)Wen Di (3 shared papers)
In The Last Decade
Wei Cang
19 papers receiving 506 citations
Wei Cang's Hit Papers
Peers
Comparison fields: 5 of 73
- Cancer Research 130
- Immunology 71
- Oncology 79
- Molecular Biology 174
- Reproductive Medicine 20
Countries citing papers authored by Wei Cang
This map shows the geographic impact of Wei Cang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Cang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Cang more than expected).
Fields of papers citing papers by Wei Cang
This network shows the impact of papers produced by Wei Cang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Cang. The network helps show where Wei Cang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Cang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression Hit paper breakdown → | 2022 | 241 |
| 2 | 2021 | 61 | |
| 3 | 2021 | 42 | |
| 4 | 2019 | 37 | |
| 5 | 2022 | 22 | |
| 6 | 2023 | 19 | |
| 7 | 2023 | 18 | |
| 8 | 2019 | 18 | |
| 9 | 2019 | 17 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 6 | |
| 12 | 2018 | 6 | |
| 13 | 2020 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2023 | 2 | |
| 18 | 2023 | 1 | |
| 19 | 2024 | 1 |
About Wei Cang
Wei Cang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health, Immunology and Reproductive Medicine, having authored 19 papers that have together received 511 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (3 papers), Gestational Trophoblastic Disease Studies (3 papers), Endometrial and Cervical Cancer Treatments (2 papers), Epigenetics and DNA Methylation (2 papers), Cervical Cancer and HPV Research (2 papers), Immune cells in cancer (2 papers), Cancer Mechanisms and Therapy (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Cancer Research (130 citations), Immunology (71 citations), Oncology (79 citations), Molecular Biology (174 citations) and Reproductive Medicine (20 citations). Wei Cang has collaborated with scholars based in China and Thailand. Frequent co-authors include Yu Gu, Lihua Chen, Pengming Sun, Yang Xiang, Lihua Qiu, Liying Gu, Anyue Wu, Wen Di, Yang Xiang and Junjun Yang. Their work appears in journals such as Frontiers in Oncology, International Immunopharmacology, Acta Obstetricia Et Gynecologica Scandinavica, International Journal of Gynecological Cancer and Biomedicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.